Health and Fitness New NIH-funded Memory Drug Moves Into Phase 1 Clinical Study by Press on December 31, 2015 Press Author More in Health and Fitness: On Hantavirus, Park Forest Officials Urge Caution May 18, 2026 Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026 Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026 Collaboration between NIH and Tetra Discovery Partners leads to development of treatment that may affect cognition